CN112029743A - 一种6-溴茚酮的生物酶催化合成方法 - Google Patents

一种6-溴茚酮的生物酶催化合成方法 Download PDF

Info

Publication number
CN112029743A
CN112029743A CN202010967924.4A CN202010967924A CN112029743A CN 112029743 A CN112029743 A CN 112029743A CN 202010967924 A CN202010967924 A CN 202010967924A CN 112029743 A CN112029743 A CN 112029743A
Authority
CN
China
Prior art keywords
leu
ala
glu
ser
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010967924.4A
Other languages
English (en)
Inventor
谢志军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangxi Bontac Green Biocatalysis Ecoindustrial Park Co ltd
Original Assignee
Jiangxi Bontac Green Biocatalysis Ecoindustrial Park Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangxi Bontac Green Biocatalysis Ecoindustrial Park Co ltd filed Critical Jiangxi Bontac Green Biocatalysis Ecoindustrial Park Co ltd
Priority to CN202010967924.4A priority Critical patent/CN112029743A/zh
Publication of CN112029743A publication Critical patent/CN112029743A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/104Aminoacyltransferases (2.3.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • C12N15/1031Mutagenizing nucleic acids mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/24Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26Ketones
    • C12P7/38Cyclopentanone- or cyclopentadione-containing products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

本发明涉及一种6‑溴茚酮的生物酶催化合成方法,属于生物制药领域,将具有SEQ ID NO.2氨基酸序列的转肽酶定点突变型转肽酶具有SEQ ID NO.1所示的氨基酸序列,再将对溴苯丙酸加入到的甲醇中,搅拌充分溶解后,再加入pH=2.0的磷酸二氢钾缓冲溶液,0.95KU的定点突变型转肽酶,室温下搅拌20h,蒸干溶剂后,过滤得粗品;再用甲醇/水重结晶得到6‑溴茚酮精品。本发明采用酶突变技术制备的活性转肽酶酶替代了传统的化学合成过程。反应条件温和简单,产生极少的三废。比传统的化学法合成效率更高,收率高,纯度高。

Description

一种6-溴茚酮的生物酶催化合成方法
技术领域
本发明属于生物制药领域,具体涉及一种采用酶突变技术制备药
物中间体的方法。
背景技术
茚环结构存在于天然产物、合成药物、农药等分子中,茚酮作为原料用于生物活性化合物的合成具有很强的工业应用前景,同时也再有机发光材料、染料合成方面也有应用,还作为可见光除去的有机保护基团。
天然存在的茚酮化合物有100多个,具有茚酮结构的分子显示出多样的生物活性,例如平滑肌松弛活性、环氧化酶抑制剂等,还有从海洋藻类青菌中分离的具有抑制人血管内皮因子生长的活性,在肿瘤血管生成调节方面具有很强的应用。但是天然提取的两远远赶不上实际需求,因此人工合成茚酮类化合物成为目前发展的趋势。
目前茚酮类化合物一般采用化学合成,步骤繁多,所需物料苛刻,而且所产三废较多,对环境所造成的污染较大。对于6-溴茚酮的合成,目前主要合成途径是以对溴苄溴为原料,经与丙二酸二乙酯反应,在碱性条件下生成二元羧酸,然后通过热脱去一个羧酸,然后酰化经傅克反应生成目标产物。此工艺涉及较多高危化学品,傅克反应还需用到大量的无水氯化铝,工艺要求高,收率低,且危险因素大,三废较多,对环境不友好。
酶作为高效的催化剂因绿色环保,反应条件温和而受到极大的关注。近些年来,越来越多的酶催化多功能性被发现。特别是转肽酶,因其稳定性好,对底物适应范围广以及能高效地催化多种类型的反应而被认为是最有用的酶之一。对酶多功能性的研究,不仅拓宽了我们对生物催化的认知,并且拓展了酶催化的应用范围。转肽酶催化多能性的工作已经被广泛报道,包括aldol反应,Michael反应,Mannich反应,马氏加成反应以及Henry反应等,本发明拟利用生物酶突变技术,获取一种可以有效催化傅克反应获得6-溴茚酮的突变型转肽酶,现有技术中尚未由关于转肽酶突变得到6-溴茚酮的技术报道。
发明内容
本发明针对6-溴茚酮的化学合成,充分利用定点突变型转肽酶在有机溶剂中的良好催化活性,对最后的傅克反应步骤进行了生物酶催化改造,结果获得了良好的产品转化率,而且产品单一,后处理简单,几乎没有三废产生,真正做到绿色环保。
本发明是通过以下方式实现的:
一种6-溴茚酮的生物酶催化合成方法,所述生物酶为定点突变型转肽酶,具有SEQID NO.1所示的氨基酸序列。
所述SEQ ID NO.1所示的氨基酸序列的突变型转肽酶在合成6-溴茚酮的应用。
所述的合成方法,具体包括以下步骤:
(1)将对溴苯丙酸加入到的甲醇中,搅拌充分溶解后,再加入pH=2.0的磷酸二氢钾缓冲溶液,0.95KU的定点突变型转肽酶,室温下搅拌20h,蒸干溶剂后,过滤即得粗品;
(2)再用甲醇/水重结晶得到6-溴茚酮精品。
进一步的:
SEQ ID NO.1突变体的获得:突变体文库构建及高通量筛选方法。
突变体文库的构建:
为了提高转肽酶的活力,以重组表达载体PET-28a(+)-BS为DNA模板,通过易错PCR的方法构建一个随机突变体文库,并通过调整易错PCR反应体系中Mg2+和Mn2+浓度以及dCTP和dTTP寡核苷酸浓度,使该突变体文库的碱基错配率为千分之十,即保证一个突变体有2到6个氨基酸发生突变,构建突变体文库的具体过程如下。易错PCR反应体系和条件:
易错PCR反应体系:
Figure BDA0002683020260000031
Figure BDA0002683020260000041
易错PCR反应条件是:先90℃预变性10min;然后98℃变性60s,60℃退火2min,80℃1.5min,共30个循环;最后75℃延伸10min。
将上述得到的易错PCR产物切胶回收纯化,与原核表达载体pET28a(+)连接后转化重组基因工程菌,即得到一个库容量大的突变体文库。
筛选突变:
从上述突变子文库中筛选了约20000个克隆,得到10个数值变化明显的突变子。接着对这10个突变子进行摇瓶筛选。具体过程为:将这10个突变子接种于含100mlLB培养基的500ml摇瓶中进行发酵及诱导,并通过HPLC法测定活力,得到1个比对照酶活力高2-5倍的突变子,命名为SEQ ID NO.1,经过测序,结果显示如下位点发生突变:I24A、L94T、P179M、S389M、G579R、P726L、S862V、A1070D。
本发明的有益效果
(1)采用酶突变技术制备的活性转肽酶酶替代了传统的化学合成过程。反应条件温和简单,只产生极少的三废。
(2)比传统的化学法合成效产物率更高,收率高,纯度高。
具体实施方式
以下实施例及其说明用于解释本发明,但并不构成对本发明的不当限定。
本申请中下述实施例中所使用的方法如无特殊说明均为常规方法,如《分子克隆实验指南》(J.萨姆布鲁克,D.W.拉塞尔著,黄培堂,汪嘉玺,朱厚础,等译。第3版,北京:科学出版社,2002)中所述的方法进行。同时,本发明中的氨基酸无特别说明外均用其缩写或代号标明。
6-溴茚酮与突变型转肽酶傅克反应可能的机理为:
羰基被突变型转肽酶活性位点中的丝氨酸活化,然后质子化的羰基被富电子的其他基团进攻,形成一个烯胺正离子的中间体,在丝氨酸中氧负离子的作用下脱去质子,得到单取代的氧化物。在极性质子性溶剂甲醇中,单取代的产物中羟基被活泼质子夺走生成一分子水,然后生成亚胺离子,经过分子间的亚胺烯胺互变,得到了一个新的烯胺正离子,然后又一分子进攻此中间体,形成新的烯胺正离子,再次通过丝氨酸中氧负离子夺去中间体中的质子,最后从突变型转肽酶中脱落得到最终6-溴茚酮。
实施例1
SEQ ID NO.1突变体的制备:突变体文库构建及高通量筛选方法:
突变体文库的构建:
为了提高转肽酶的活力,以重组表达载体PET-28a(+)-BS为DNA模板,通过易错PCR的方法构建一个随机突变体文库,并通过调整易错PCR反应体系中Mg2+和Mn2+浓度以及dCTP和dTTP寡核苷酸浓度,使该突变体文库的碱基错配率为千分之十,即保证一个突变体有2到6个氨基酸发生突变,构建突变体文库的具体过程如下。易错PCR反应体系和条件:
易错PCR反应体系:
10×Buffer 8μL
2mmol/L dNTPS 3μL
100mmol/L dCTP 0.7μL
100mmol/L dTTP 0.7μL
10mmol/L MnCl 2μL
50mmol/L MgSO4 2μL
引物T7 promoter 0.5μL
引物T7 Terminator 1μL
模板pET-7β-HSDH-wt 0.5μL
Taq DNA聚合酶 0.7μL
ddH2O 25μL
易错PCR反应条件是:先90℃预变性10min;然后98℃变性60s,60℃退火2min,80℃1.5min,共30个循环;最后75℃延伸10min。
将上述得到的易错PCR产物切胶回收纯化,与原核表达载体pET28a(+)连接后转化重组基因工程菌,即得到一个库容量大的突变体文库。
筛选突变:
从上述突变子文库中筛选了约20000个克隆,得到10个数值变化明显的突变子。接着对这10个突变子进行摇瓶筛选。具体过程为:将这10个突变子接种于含100ml LB培养基的500ml摇瓶中进行发酵及诱导,并通过HPLC法测定活力,得到1个比对照酶活力高2-5倍的突变子,命名为SEQ ID NO.1,经过测序,结果显示如下位点发生突变:I24A、L94T、P179M、S389M、G579R、P726L、S862V、A1070D。
实施例2
将229g对溴苯丙酸(1.0mol)加入到1000ml的甲醇中,搅拌充分溶解后,再加入200ml 5mM的磷酸二氢钾缓冲溶液(pH=2.0),0.95KU的突变后转肽酶,室温下搅拌20h,蒸干有机溶剂后,过滤即得粗品,再用甲醇/水重结晶得到6-溴茚酮精品197.50g,转化率为93.83%。
对比例1
将229g对溴苯丙酸(1.0mol)加入到1000ml的甲醇中,搅拌充分溶解后,再加入200ml 5mM的磷酸二氢钾缓冲溶液(pH=2.0),0.95KU的未突变的转肽酶,其氨基酸序列如SEQ ID NO.2所示,室温下搅拌20h,蒸干有机溶剂后,过滤即得粗品,再用甲醇/水重结晶得到6-溴茚酮精品85.2g,转化率为40.5%。
序列表
<110> 江西邦泰绿色生物合成生态产业园发展有限公司
<120> 一种6-溴茚酮的生物酶催化合成方法
<160> 2
<170> SIPOSequenceListing 1.0
<210> 2
<211> 1090
<212> PRT
<213> 未知
<400> 2
Met Lys Ser Pro Lys Lys Arg Arg Ser Tyr Leu Thr Val Pro Glu Lys
1 5 10 15
Thr Asn Arg Leu Leu Ser Gly Ala Ile Val Ala Leu Ala Ile Ile Ala
20 25 30
Val Arg Leu Trp His Leu Ala Val Val Glu His Asp Gln Lys Leu Glu
35 40 45
Glu Ala Tyr Lys Pro Gln Lys Arg Val Ile Pro Glu Leu Ile Glu Arg
50 55 60
Ala Thr Ile Cys Asp Arg Phe Gly Lys Val Leu Ala Glu Asn Lys Met
65 70 75 80
Gln Tyr Asp Val Ser Val Ala Tyr Ser Ala Ile Arg Asp Thr Pro Ala
85 90 95
Arg Ala Trp Arg Ala Arg Ala Asp Gly Thr Arg Glu Leu Ile Pro Val
100 105 110
Arg Lys Asn Tyr Ile Ala Arg Leu Ala Gln Leu Leu Ala Gln Glu Leu
115 120 125
His Leu Asp Lys Asp Thr Ile Glu Asp Asn Ile His Ala Lys Ala Ser
130 135 140
Val Leu Gly Ser Val Pro Tyr Leu Val Gln Ala Asn Val Ser Glu Arg
145 150 155 160
Thr Tyr Leu Arg Leu Lys Met Met Met Lys His Trp Pro Gly Leu His
165 170 175
Val Glu Met Ser Val Arg Arg Tyr Tyr Pro Met Gly Lys Thr Ala Ser
180 185 190
Asp Ile Leu Gly Tyr Val Gly Pro Ile Ser Ala Gln Glu Tyr Lys Arg
195 200 205
Val Thr His Glu Leu Ser Lys Leu Arg Glu Cys Val Arg Ala Tyr Glu
210 215 220
Glu Gly Glu Asn Pro Lys Phe Pro Glu Gly Leu Ala Ser Ile Asp Gln
225 230 235 240
Val Arg Ser Leu Leu Asn Ser Leu Glu Asn Asn Ala Tyr Ser Leu Asn
245 250 255
Ala Leu Val Gly Lys Val Gly Ile Glu Ala Tyr Cys Asp Ala Ser Leu
260 265 270
Arg Gly Gln Leu Gly Lys Lys Thr Val Leu Val Asp Arg Arg Gly Asn
275 280 285
Phe Ile Gln Gly Leu Asn Glu Ile Glu Ala Ile Ser Gly Lys Lys Leu
290 295 300
Gln Leu Thr Leu Ser Thr Glu Leu Gln Ala Phe Ala Asp Ala Leu Leu
305 310 315 320
Leu Asp His Glu Lys Thr Glu Gln Phe Arg Ser Ala Gln Ser Leu Lys
325 330 335
Lys Gln Lys Phe Leu Pro Pro Leu Phe Pro Trp Ile Lys Gly Gly Ala
340 345 350
Ile Ile Ala Leu Asp Pro Asn Asn Gly Gln Ile Leu Ala Met Ala Ser
355 360 365
Ser Pro Arg Tyr His Asn Asn Asp Phe Ile Asp Met Arg Asp Ala Asp
370 375 380
Ser Glu Ala Arg Met Ala Val Tyr Arg Trp Leu Glu Asn Thr Glu His
385 390 395 400
Ile Ala Glu Val Tyr Asp Arg Lys Val Pro Leu Arg Arg Glu Arg Arg
405 410 415
Ser Ser Leu Thr Gly Leu Cys Tyr Asp Glu Glu Leu Ser Leu Thr Phe
420 425 430
Asp Tyr Phe Leu Asp Phe Ile Leu Pro Asn Thr Ser Glu Val Lys Ser
435 440 445
Val Ile Lys Arg Tyr Gly Thr Val Asn Asn Ala Val Lys Ile Gln Arg
450 455 460
Ala Met Gly Arg Leu Leu Asp Leu Phe Ser Tyr Ser Glu Gly His Cys
465 470 475 480
Ser Cys Ser Ser Ile Phe Asp Ala Val Phe Pro Val Glu Gln Glu His
485 490 495
Ile Ala Val Gly Arg Val Ile Ser Ile Lys Gln Gln Lys Trp Ile Ala
500 505 510
Arg Cys His Lys Ala His Glu Arg Glu Ile Glu Glu Ile Lys Gln Glu
515 520 525
Leu Asp Pro Phe Phe Ala Glu Leu Pro Ala Asn Tyr Asp Lys Leu Leu
530 535 540
Leu Val Asp Leu Phe Gln Met Val Val Asp Pro Ser Lys Ile Asp Pro
545 550 555 560
Glu Leu Leu Ala Ser Val Ala Ser Phe Ser Leu Ser Glu Phe Phe Glu
565 570 575
Cys Gln Arg His Tyr Val Ala Leu Arg Ser Ala Phe Ser Lys Ile Val
580 585 590
Glu Asp Ile Phe Thr Glu Leu Asp Phe Lys Glu Trp Arg Lys Leu Tyr
595 600 605
Phe Ala Lys Phe Leu Glu Val Lys Arg Lys Glu Glu Asn Glu Arg Lys
610 615 620
Gln Arg Tyr Pro Thr Pro Tyr Val Asp Tyr Leu Ala Glu Glu Gln Arg
625 630 635 640
Ala Gln Tyr Arg Asp Phe Arg Arg Cys Tyr Leu Asp Lys Phe Leu Ala
645 650 655
Tyr Leu Leu Ser Gly Gln Gly Asp Ile Glu Asn Gln Lys Ala Tyr Tyr
660 665 670
Glu Ala Leu Ser Val Trp Lys Arg Glu Leu Glu Asn Gly Ala His Gln
675 680 685
Ala Leu Pro Trp Tyr Glu His Tyr Glu Phe Leu Lys Gln Lys Phe Ser
690 695 700
Asp Ser Ser Ile Asp Leu Leu Arg Leu Phe Leu Ser Phe Arg Glu Phe
705 710 715 720
Ser Glu Leu Gln Arg Leu Leu Tyr Gly Asn Tyr Ala Pro Met Leu Thr
725 730 735
Arg Asn Val Pro Gln Lys Glu Gln Asp Leu Ala Ala Ala Phe Tyr Pro
740 745 750
Ala Tyr Gly Tyr Gly Tyr Leu Arg Ser His Ala Phe Gly Gln Ala Ala
755 760 765
Thr Leu Gly Ser Ile Phe Lys Leu Val Ser Ala Tyr Ser Val Leu Ser
770 775 780
Gln Glu Val Met Arg Gly Asn Val Asp Val Asp Tyr Leu Ser Arg Leu
785 790 795 800
Leu Val Ile Ile Asp Arg Lys Ser Phe Gly Tyr Ala Ser Ala Lys Pro
805 810 815
His Val Gly Phe Phe Lys Asp Gly Thr Pro Ile Pro Ser Phe Tyr Arg
820 825 830
Gly Gly Ile Leu Pro Lys Asn Asp Tyr Ser Gly Arg Gly Arg Ile Asp
835 840 845
Leu Ile Ser Ala Leu Glu Met Ser Ser Asn Pro Tyr Phe Val Leu Leu
850 855 860
Val Gly Glu Tyr Leu Ser Asp Pro Glu Asp Leu Cys His Ala Ala Ala
865 870 875 880
Leu Phe Gly Phe Gly Glu Lys Thr Gly Val Gly Leu Leu Gly Glu Tyr
885 890 895
Ala Gly Ala Val Pro Gln Asp Val Ala Tyr Asn Arg Ser Gly Leu Tyr
900 905 910
Ala Thr Ala Ile Gly Gln His Thr Leu Ile Val Thr Pro Leu Gln Thr
915 920 925
Ala Val Met Met Ala Ser Leu Val Asn Gly Gly Thr Leu Tyr Val Pro
930 935 940
Ser Leu Val Leu Gly Glu Trp Asn Gly Glu Glu Phe Ser Pro Thr Pro
945 950 955 960
Pro Met Lys Lys Arg Asp Val Phe Met Pro Glu Cys Ile Thr Glu Leu
965 970 975
Phe Lys Ser Gly Met His Asn Val Ile Trp Gly Asn Tyr Gly Thr Thr
980 985 990
Arg Ser Ile Arg Asp Gln Phe Ser Pro Glu Leu Leu Thr Arg Ile Ile
995 1000 1005
Gly Lys Thr Ser Thr Ala Glu Ser Ile Val Arg Val Gly Leu Asp Arg
1010 1015 1020
Gln Tyr Gly Ser Met Lys Met Lys His Val Trp Phe Ala Ala Val Gly
1025 1030 1035 1040
Phe Ser Asp Glu Glu Leu Met His Pro Asp Ile Val Val Ile Val Tyr
1045 1050 1055
Leu Arg Leu Gly Glu Phe Gly Arg Asp Ala Ala Pro Ile Asp Val Lys
1060 1065 1070
Met Ile Glu Lys Trp Glu Lys Ile Arg Lys Arg Glu Asn Phe Ser Ser
1075 1080 1085
Met Tyr
1090
<210> 2
<211> 1090
<212> PRT
<213> 未知
<400> 2
Met Lys Ser Pro Lys Lys Arg Arg Ser Tyr Leu Thr Val Pro Glu Lys
1 5 10 15
Thr Asn Arg Leu Leu Ser Gly Ile Ile Val Ala Leu Ala Ile Ile Ala
20 25 30
Val Arg Leu Trp His Leu Ala Val Val Glu His Asp Gln Lys Leu Glu
35 40 45
Glu Ala Tyr Lys Pro Gln Lys Arg Val Ile Pro Glu Leu Ile Glu Arg
50 55 60
Ala Thr Ile Cys Asp Arg Phe Gly Lys Val Leu Ala Glu Asn Lys Met
65 70 75 80
Gln Tyr Asp Val Ser Val Ala Tyr Ser Ala Ile Arg Asp Leu Pro Ala
85 90 95
Arg Ala Trp Arg Ala Arg Ala Asp Gly Thr Arg Glu Leu Ile Pro Val
100 105 110
Arg Lys Asn Tyr Ile Ala Arg Leu Ala Gln Leu Leu Ala Gln Glu Leu
115 120 125
His Leu Asp Lys Asp Thr Ile Glu Asp Asn Ile His Ala Lys Ala Ser
130 135 140
Val Leu Gly Ser Val Pro Tyr Leu Val Gln Ala Asn Val Ser Glu Arg
145 150 155 160
Thr Tyr Leu Arg Leu Lys Met Met Met Lys His Trp Pro Gly Leu His
165 170 175
Val Glu Pro Ser Val Arg Arg Tyr Tyr Pro Met Gly Lys Thr Ala Ser
180 185 190
Asp Ile Leu Gly Tyr Val Gly Pro Ile Ser Ala Gln Glu Tyr Lys Arg
195 200 205
Val Thr His Glu Leu Ser Lys Leu Arg Glu Cys Val Arg Ala Tyr Glu
210 215 220
Glu Gly Glu Asn Pro Lys Phe Pro Glu Gly Leu Ala Ser Ile Asp Gln
225 230 235 240
Val Arg Ser Leu Leu Asn Ser Leu Glu Asn Asn Ala Tyr Ser Leu Asn
245 250 255
Ala Leu Val Gly Lys Val Gly Ile Glu Ala Tyr Cys Asp Ala Ser Leu
260 265 270
Arg Gly Gln Leu Gly Lys Lys Thr Val Leu Val Asp Arg Arg Gly Asn
275 280 285
Phe Ile Gln Gly Leu Asn Glu Ile Glu Ala Ile Ser Gly Lys Lys Leu
290 295 300
Gln Leu Thr Leu Ser Thr Glu Leu Gln Ala Phe Ala Asp Ala Leu Leu
305 310 315 320
Leu Asp His Glu Lys Thr Glu Gln Phe Arg Ser Ala Gln Ser Leu Lys
325 330 335
Lys Gln Lys Phe Leu Pro Pro Leu Phe Pro Trp Ile Lys Gly Gly Ala
340 345 350
Ile Ile Ala Leu Asp Pro Asn Asn Gly Gln Ile Leu Ala Met Ala Ser
355 360 365
Ser Pro Arg Tyr His Asn Asn Asp Phe Ile Asp Met Arg Asp Ala Asp
370 375 380
Ser Glu Ala Arg Ser Ala Val Tyr Arg Trp Leu Glu Asn Thr Glu His
385 390 395 400
Ile Ala Glu Val Tyr Asp Arg Lys Val Pro Leu Arg Arg Glu Arg Arg
405 410 415
Ser Ser Leu Thr Gly Leu Cys Tyr Asp Glu Glu Leu Ser Leu Thr Phe
420 425 430
Asp Tyr Phe Leu Asp Phe Ile Leu Pro Asn Thr Ser Glu Val Lys Ser
435 440 445
Val Ile Lys Arg Tyr Gly Thr Val Asn Asn Ala Val Lys Ile Gln Arg
450 455 460
Ala Met Gly Arg Leu Leu Asp Leu Phe Ser Tyr Ser Glu Gly His Cys
465 470 475 480
Ser Cys Ser Ser Ile Phe Asp Ala Val Phe Pro Val Glu Gln Glu His
485 490 495
Ile Ala Val Gly Arg Val Ile Ser Ile Lys Gln Gln Lys Trp Ile Ala
500 505 510
Arg Cys His Lys Ala His Glu Arg Glu Ile Glu Glu Ile Lys Gln Glu
515 520 525
Leu Asp Pro Phe Phe Ala Glu Leu Pro Ala Asn Tyr Asp Lys Leu Leu
530 535 540
Leu Val Asp Leu Phe Gln Met Val Val Asp Pro Ser Lys Ile Asp Pro
545 550 555 560
Glu Leu Leu Ala Ser Val Ala Ser Phe Ser Leu Ser Glu Phe Phe Glu
565 570 575
Cys Gln Gly His Tyr Val Ala Leu Arg Ser Ala Phe Ser Lys Ile Val
580 585 590
Glu Asp Ile Phe Thr Glu Leu Asp Phe Lys Glu Trp Arg Lys Leu Tyr
595 600 605
Phe Ala Lys Phe Leu Glu Val Lys Arg Lys Glu Glu Asn Glu Arg Lys
610 615 620
Gln Arg Tyr Pro Thr Pro Tyr Val Asp Tyr Leu Ala Glu Glu Gln Arg
625 630 635 640
Ala Gln Tyr Arg Asp Phe Arg Arg Cys Tyr Leu Asp Lys Phe Leu Ala
645 650 655
Tyr Leu Leu Ser Gly Gln Gly Asp Ile Glu Asn Gln Lys Ala Tyr Tyr
660 665 670
Glu Ala Leu Ser Val Trp Lys Arg Glu Leu Glu Asn Gly Ala His Gln
675 680 685
Ala Leu Pro Trp Tyr Glu His Tyr Glu Phe Leu Lys Gln Lys Phe Ser
690 695 700
Asp Ser Ser Ile Asp Leu Leu Arg Leu Phe Leu Ser Phe Arg Glu Phe
705 710 715 720
Ser Glu Leu Gln Arg Pro Leu Tyr Gly Asn Tyr Ala Pro Met Leu Thr
725 730 735
Arg Asn Val Pro Gln Lys Glu Gln Asp Leu Ala Ala Ala Phe Tyr Pro
740 745 750
Ala Tyr Gly Tyr Gly Tyr Leu Arg Ser His Ala Phe Gly Gln Ala Ala
755 760 765
Thr Leu Gly Ser Ile Phe Lys Leu Val Ser Ala Tyr Ser Val Leu Ser
770 775 780
Gln Glu Val Met Arg Gly Asn Val Asp Val Asp Tyr Leu Ser Arg Leu
785 790 795 800
Leu Val Ile Ile Asp Arg Lys Ser Phe Gly Tyr Ala Ser Ala Lys Pro
805 810 815
His Val Gly Phe Phe Lys Asp Gly Thr Pro Ile Pro Ser Phe Tyr Arg
820 825 830
Gly Gly Ile Leu Pro Lys Asn Asp Tyr Ser Gly Arg Gly Arg Ile Asp
835 840 845
Leu Ile Ser Ala Leu Glu Met Ser Ser Asn Pro Tyr Phe Ser Leu Leu
850 855 860
Val Gly Glu Tyr Leu Ser Asp Pro Glu Asp Leu Cys His Ala Ala Ala
865 870 875 880
Leu Phe Gly Phe Gly Glu Lys Thr Gly Val Gly Leu Leu Gly Glu Tyr
885 890 895
Ala Gly Ala Val Pro Gln Asp Val Ala Tyr Asn Arg Ser Gly Leu Tyr
900 905 910
Ala Thr Ala Ile Gly Gln His Thr Leu Ile Val Thr Pro Leu Gln Thr
915 920 925
Ala Val Met Met Ala Ser Leu Val Asn Gly Gly Thr Leu Tyr Val Pro
930 935 940
Ser Leu Val Leu Gly Glu Trp Asn Gly Glu Glu Phe Ser Pro Thr Pro
945 950 955 960
Pro Met Lys Lys Arg Asp Val Phe Met Pro Glu Cys Ile Thr Glu Leu
965 970 975
Phe Lys Ser Gly Met His Asn Val Ile Trp Gly Asn Tyr Gly Thr Thr
980 985 990
Arg Ser Ile Arg Asp Gln Phe Ser Pro Glu Leu Leu Thr Arg Ile Ile
995 1000 1005
Gly Lys Thr Ser Thr Ala Glu Ser Ile Val Arg Val Gly Leu Asp Arg
1010 1015 1020
Gln Tyr Gly Ser Met Lys Met Lys His Val Trp Phe Ala Ala Val Gly
1025 1030 1035 1040
Phe Ser Asp Glu Glu Leu Met His Pro Asp Ile Val Val Ile Val Tyr
1045 1050 1055
Leu Arg Leu Gly Glu Phe Gly Arg Asp Ala Ala Pro Ile Ala Val Lys
1060 1065 1070
Met Ile Glu Lys Trp Glu Lys Ile Arg Lys Arg Glu Asn Phe Ser Ser
1075 1080 1085
Met Tyr
1090

Claims (3)

1.一种6-溴茚酮的生物酶催化合成方法,其特征在于,所述生物酶为定点突变型转肽酶,具有SEQ ID NO.1所示的氨基酸序列。
2.权利要求1所述SEQ ID NO.1所示的氨基酸序列的突变型转肽酶在合成6-溴茚酮的应用。
3.根据权利要求1所述的合成方法,其特征在于:具体包括以下步骤:
(1)将对溴苯丙酸加入到的甲醇中,搅拌充分溶解后,再加入pH=2.0的磷酸二氢钾缓冲溶液,0.95KU的定点突变型转肽酶,室温下搅拌20h,蒸干溶剂后,过滤即得粗品;
(2)再用甲醇/水重结晶得到6-溴茚酮精品。
CN202010967924.4A 2020-09-15 2020-09-15 一种6-溴茚酮的生物酶催化合成方法 Pending CN112029743A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010967924.4A CN112029743A (zh) 2020-09-15 2020-09-15 一种6-溴茚酮的生物酶催化合成方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010967924.4A CN112029743A (zh) 2020-09-15 2020-09-15 一种6-溴茚酮的生物酶催化合成方法

Publications (1)

Publication Number Publication Date
CN112029743A true CN112029743A (zh) 2020-12-04

Family

ID=73590220

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010967924.4A Pending CN112029743A (zh) 2020-09-15 2020-09-15 一种6-溴茚酮的生物酶催化合成方法

Country Status (1)

Country Link
CN (1) CN112029743A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113881647A (zh) * 2020-12-28 2022-01-04 上海合全药物研发有限公司 转氨酶及其在制备光学纯手性胺中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104418700A (zh) * 2013-08-23 2015-03-18 无锡昱天生物医药有限公司 一种7-溴茚的合成方法
CN104910001A (zh) * 2015-04-13 2015-09-16 徐伟 一种新的5-氯-1-茚酮的合成方法
CN109678685A (zh) * 2018-07-04 2019-04-26 中南民族大学 一种1-茚酮及其衍生物的制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104418700A (zh) * 2013-08-23 2015-03-18 无锡昱天生物医药有限公司 一种7-溴茚的合成方法
CN104910001A (zh) * 2015-04-13 2015-09-16 徐伟 一种新的5-氯-1-茚酮的合成方法
CN109678685A (zh) * 2018-07-04 2019-04-26 中南民族大学 一种1-茚酮及其衍生物的制备方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
VAN LENT, S., ET AL.: "Genbank accession number:AFS26364.1" *
徐霞;谢闺娥;杜晶春;: "耐甲氧西林金黄色葡萄球菌PBP2a转肽酶区的克隆表达及纯化鉴定" *
李冀;杨慧;唐蕊华;李晶;李琦;邵燕;呼延霆;黄庆生;师俊玲;: "耐甲氧西林金黄色葡萄球菌青霉素结合蛋白2a转肽酶区的原核表达及其纯化" *
柴凤兰等: "茚酮化合物合成方法研究进展" *
段义杰;刘建利;王翠玲;: "茚酮类化合物的研究进展" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113881647A (zh) * 2020-12-28 2022-01-04 上海合全药物研发有限公司 转氨酶及其在制备光学纯手性胺中的应用
CN113881647B (zh) * 2020-12-28 2023-11-17 上海合全药物研发有限公司 转氨酶及其在制备光学纯手性胺中的应用

Similar Documents

Publication Publication Date Title
CN111172124A (zh) 一种羰基还原酶突变体及其在制备(r)-4-氯-3-羟基-丁酸酯中的应用
CN107653233A (zh) 一种改进的转氨酶、其编码基因及表达该酶的基因工程菌
CN109401985B (zh) 一株高产peptaibols抗菌肽的ΔTlrgt2木霉工程菌及其构建方法与应用
CN108048416A (zh) 改进的酮还原酶突变体及其制备方法和应用
CN112029743A (zh) 一种6-溴茚酮的生物酶催化合成方法
CN109468346A (zh) 一种(s)-1-(2-碘-5-氟苯基)乙醇的生物制备方法
CN109468290A (zh) 一种羰基还原酶突变体、表达载体、工程菌及其应用
CN112410276A (zh) 一种2-氯-1-(3,4-二氟苯基)乙酮还原酶重组菌株及构建方法和应用
CN116926051B (zh) 一种查耳酮异构酶突变体及其制备方法和应用
CN112391362B (zh) 催化活性提高的黄酮3β-羟化酶突变体及其应用
CN117511889B (zh) 酶及其在非天然氨基酸二肽制备中的应用
CN105349557B (zh) 一种苹果酸酶基因rkme2及其重组表达载体
CN112592940B (zh) 一种n-(9-笏基甲氧羰基)-癸基氨基乙醛的生物酶合成方法
CN113621629B (zh) 一种基于丙二酰辅酶a再生的柚皮素体外酶促合成方法
CN104673808B (zh) 一种苹果酸酶基因及其重组表达载体
CN114214261B (zh) 一种表达酯酶EstS的大肠杆菌基因工程菌及其应用
CN113755458B (zh) 一种参与紫草素和/或阿卡宁生物合成的cyp82ar2蛋白及其编码基因与应用
CN117106819B (zh) 三角褐指藻CHLC基因以及编码的蛋白在叶绿素c合成中的应用
CN114480315B (zh) 一种Baeyer-Villiger单加氧酶及其在布立西坦合成中的应用
CN116426499B (zh) 一种甲基转移酶突变体、生物材料和应用
CN114149956B (zh) 一种表达酯酶EstR的大肠杆菌基因工程菌及其应用
CN117264935A (zh) 一种苯丙氨酸解氨酶突变体及其用途
CN111996222A (zh) 采用酶突变技术制备药物中间体(r)-2-(氨乙基)-4-氯苯酚的方法
JPH0568564A (ja) イネパーオキシダーゼ遺伝子
CN116515782A (zh) 一种胺脱氢酶突变体及其在手性胺醇化合物合成中的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20201204